Memantine Hydrochloride Capsule, Extended Release
Product Images NDC 59651-404

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 59651-404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Memantine-fig1.jpg (Memantine Fig1)

FDA Label Image

Package Label-principal Display Panel (Titration Pack Carton)

FDA Label Image

Memantine-fig2.jpg (Memantine Fig2)

FDA Label Image

Memantine-fig3.jpg (Memantine Fig3)

FDA Label Image

Memantine-fig4.jpg (Memantine Fig4)

FDA Label Image

Package Label-principal Display Panel (7 mg (30 Capsules Bottle))

Once-Daily Memantine Hydrochloride Extended-Release Capsules are available in a pack of 30 capsules. Each capsule contains 7 mg of Memantine hydrochloride USP. The package includes the usual dosage instructions and recommendations related to storage. The capsule should be kept at 20° to 25°C and in a tightly closed container out of reach of children. The product is made in India and distributed by Aurobindo Pharma USA, Inc. The NDC code for the product is 59651-404-30.*

FDA Label Image

Package Label-principal Display Panel (14 mg (30 Capsules Bottle))

This is a description of Memantine Hydrochloride Extended-Release Capsules. The capsules contain 14 mg of memantine hydrochloride USP and come in a pack of 30. The usual dosage is indicated in the package insert. It is recommended to store the capsules at 20° to 25°C (68° to 77°F) and dispense them in a tightly closed container as specified in the USP. The capsules should be kept out of the reach of others. The distributor is Aurobindo Pharma USA, Inc. The product is made in India.*

FDA Label Image

Package Label-principal Display Panel (21 mg (30 Capsules Bottle))

This is a description of extended-release capsules which contain Memantine hydrochloride USP 21 mg. The usual dosage information can be found in the package insert. The recommended storage temperature is between 20-25°C (68-77°F). These capsules are manufactured in India and distributed by Aurobindo Pharma USA, Inc. The label also includes prescribing information, a reminder to keep the medication out of reach of children, and instructions to dispense the drug in a tightly closed container. There is also a code and a warning not to print on the dotted lines.*

FDA Label Image

Package Label-principal Display Panel (28 mg (30 Capsules Bottle))

This is a description of an extended-release capsule of memantine hydrochloride, with each containing 26mg of ytemantine. The text advises to refer to the package insert for more information on recommended dosage. The storage temperature is recommended as between 20°C to 25°C, and the capsules must be kept in a tightly sealed container as per USP regulations. The manufacturer is Aurobindo Pharma, and the capsules are made in India. There is a code for tracking purposes, and the text recommends keeping the capsules and all drugs out of reach.*

FDA Label Image

Package Label-principal Display Panel (Titration Pack)

FDA Label Image

Chemical Structure (Memantine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.